“EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE ”. 2026. Global Journal of Public Health Medicine 8 (1 (Ongoing): 216-27. https://doi.org/10.37557/33f44713.